{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "VEGFR2PDGFRc-KitFlt-3_Inhibitor_SU014813",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An orally-active, tyrosine kinase receptor inhibitor with potential antitumor activity. SU014813 binds to and inhibits the phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR) alpha and beta, c-Kit and Fms-related tyrosine kinase 3 (Flt-3). This leads to an inhibition of cellular proliferation and angiogenesis and an induction of apoptosis.",
    "fdaUniiCode": "ZZ6VH5MZ17",
    "identifier": "C61507",
    "preferredName": "VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1967",
      "C1971"
    ],
    "synonyms": [
      "SU-14813",
      "VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813"
    ]
  }
}